{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T21:41:11Z","timestamp":1774906871659,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Specialist Dental Clinic S.C., \u017bory"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Turner syndrome (TS) is characterized by the partial or complete loss of one sex chromosome and results in growth failure, gonadal insufficiency and cardiac anomalies. Treatment with growth hormone (GH) during childhood has indisputable benefits when taking into account the low stature of TS women. Medical records and biochemical findings of 33 TS women treated with GH in childhood (GH+) were compared to those of 124 TS women who did not receive GH (GH\u2212). It seems that the GH-treated group might have had a more severe initial phenotype than the untreated group, as evidenced by higher FSH, more feeding issues in infancy, more lymphedema cases and urinary system malformations. GH+ women were significantly taller and had a better lipid profile and lower prevalence of arterial hypertension than GH\u2212 . However, they also had lower thrombocyte counts, a greater prevalence of retrognathism and nail anomalies, especially when the GH treatment was delayed. Long-term GH use was not as effective for growth as GH treatment during the initial period and seemed to have resulted in elevated creatinine levels. GH treatment in childhood has benefits in adulthood; however, adverse effects may occur, especially in individuals with treatment that is delayed or is too long.<\/jats:p>","DOI":"10.1038\/s41598-019-52332-0","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T11:03:13Z","timestamp":1572865393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Childhood growth hormone treatment in women with Turner syndrome - benefits and adverse effects"],"prefix":"10.1038","volume":"9","author":[{"given":"Tomasz","family":"Irzyniec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wac\u0142aw","family":"Je\u017c","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Lepska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5725-0137","authenticated-orcid":false,"given":"Izabela","family":"Maciejewska-Paszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Frelich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"52332_CR1","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1210\/jc.2006-0558","volume":"91","author":"K Stochholm","year":"2006","unstructured":"Stochholm, K., Juul, S., Juel, K., Naeraa, R. W. & Gravholt, C. H. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J. Clin. Endocrinol. Metab. 91, 3897\u20133902 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"52332_CR2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0430","volume":"177","author":"CH Gravholt","year":"2017","unstructured":"Gravholt, C. H. et al. Clinical practice guidelines for the care of girls and women with Turner syndrome, proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur. J. Endocrinol. 177, G1\u2013G70 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"52332_CR3","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/cen.13394","volume":"87","author":"A Cameron-Pimblett","year":"2017","unstructured":"Cameron-Pimblett, A., La Rosa, C., King, T. F. J., Davies, M. C. & Conway, G. S. The Turner syndrome life course project: Karyotype-phenotype analyses across the lifespan. Clin. Endocrinol. (Oxf) 87, 532\u2013538 (2017).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"52332_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.rmu.2016.03.003","volume":"18","author":"M Ibarra-Ram\u00edrez","year":"2016","unstructured":"Ibarra-Ram\u00edrez, M. & Mart\u00ednez-de-Villarreal, L. E. Clinical and genetic aspects of Turner\u2019s syndrome. Medicina Universitaria 18, 42\u201348 (2016).","journal-title":"Medicina Universitaria"},{"key":"52332_CR5","first-page":"130","volume":"64","author":"W Je\u017c","year":"2007","unstructured":"Je\u017c, W., Irzyniec, T. & Pyrkosz, A. Selected problems of the diagnosis of Turner\u2019s syndrome. Przeg. Lek. 64, 130\u2013133 (2007).","journal-title":"Przeg. Lek."},{"key":"52332_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5603\/EP.a2019.0016","volume":"70","author":"J Frelich","year":"2019","unstructured":"Frelich, J., Irzyniec, T., Lepska, K. & Je\u017c, W. New insights into clinical features, karyotypes age at diagnosis in in women with Turner syndrome. Endokrynol. Pol. 70, 342\u2013349, https:\/\/doi.org\/10.5603\/EP.a2019.0016 (2019).","journal-title":"Endokrynol. Pol."},{"key":"52332_CR7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/HJH.0000000000000599","volume":"33","author":"K De Groote","year":"2015","unstructured":"De Groote, K. et al. Arterial hypertension in Turner syndrome: a review of the literature and a practical approach for diagnosis and treatment. J. Hypertens. 33, 1342\u20131351 (2015).","journal-title":"J. Hypertens."},{"key":"52332_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5603\/AH.2016.0023","volume":"20","author":"TJ Irzyniec","year":"2016","unstructured":"Irzyniec, T. J. & Je\u017c, W. A beneficial effect of estradiol on blood pressure, not on glucose and lipids levels in women with Turner syndrome. Arterial Hypertens. 20, 206\u2013210 (2016).","journal-title":"Arterial Hypertens."},{"key":"52332_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4137\/CMED.S38201","volume":"9","author":"J Devesa","year":"2016","unstructured":"Devesa, J., Almengl\u00f3, C. & Devesa, P. Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth? Clin. Med. Insights. Endocrinol. Diabetes 9, 47\u201371 (2016).","journal-title":"Clin. Med. Insights. Endocrinol. Diabetes"},{"key":"52332_CR10","doi-asserted-by":"crossref","unstructured":"Melmed, S., Kleinberg, D. & Ho, K. Pituitary Physiology and Diagnostic Evaluation in: Williams Textbook of Endocrinology, 12th ed. (eds Melmed, S., Polonsky, K. S., Reed Larsen, P., Kronenberg, H. M.) 175\u2013228 (Saunders Elsevier, Philadelphia, 2011).","DOI":"10.1016\/B978-1-4377-0324-5.00008-0"},{"key":"52332_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3109\/09513590.2013.872236","volume":"30","author":"TJ Irzyniec","year":"2014","unstructured":"Irzyniec, T. J. & Je\u017c, W. The influence of hormonal replacement and growth hormone treatment on the lipids in Turner syndrome. Gynecol. Endocrinol. 30, 250\u2013253 (2014).","journal-title":"Gynecol. Endocrinol."},{"key":"52332_CR12","first-page":"343","volume":"71","author":"EM Bannink","year":"2009","unstructured":"Bannink, E. M., van der Palen, R. L., Mulder, P. G. & de Muinck Keizer-Schrama, S. M. Long- term follow-up of GH\u2212 treated girls with Turner syndrome:metabolic consequences. Horm. Res. 71, 343\u2013349 (2009).","journal-title":"Horm. Res."},{"key":"52332_CR13","doi-asserted-by":"crossref","unstructured":"Styne, D. M. & Grumbach, M. M. Puberty: Ontogeny, Neuroendocrinology, Physiology, and Disorders. Pituitary Physiology and Diagnostic Evaluation in Williams Textbook of Endocrinology, 12th ed. (ed. Melmed, S., Polonsky, K.S., Reed Larsen, P., Kronenberg, H.M.) 1054\u20131201 (Saunders Elsevier, Philadelphia, 2011).","DOI":"10.1016\/B978-1-4377-0324-5.00025-0"},{"key":"52332_CR14","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1210\/jc.2017-00214","volume":"102","author":"CA Quigley","year":"2017","unstructured":"Quigley, C. A. et al. Mortality in Children Receiving Growth Hormone Treatment of Growth Disorders: Data From the Genetics and Neuroendocrinology of Short Stature International Study. J. Clin. Endocrinol. Metab. 102, 3195\u20133205 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"52332_CR15","first-page":"235","volume":"14","author":"Y Nishi","year":"2017","unstructured":"Nishi, Y. & Tanaka, T. Growth Hormone Treatment and Adverse Events. Ped. Endocrinol. Rev. 14, 235\u2013239 (2017).","journal-title":"Ped. Endocrinol. Rev."},{"key":"52332_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13052-016-0302-3","volume":"42","author":"L Iughetti","year":"2016","unstructured":"Iughetti, L. et al. Long-term safety and efficacy of Omnitrope, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study. Ital. J. Pediatr. 42, 93, https:\/\/doi.org\/10.1186\/s13052-016-0302-3 (2016).","journal-title":"Ital. J. Pediatr."},{"key":"52332_CR17","first-page":"47","volume":"68","author":"A Frelich","year":"2017","unstructured":"Frelich, A., Frelich, J., Je\u017c, W. & Irzyniec, T. Selected clinical features of the head and neck in women with Turner syndrome and the 45,X\/46,XY karyotype. Endokrynol. Pol. 68, 47\u201352 (2017).","journal-title":"Endokrynol. Pol."},{"key":"52332_CR18","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1210\/jc.2016-2046","volume":"102","author":"AJ Swerdlow","year":"2017","unstructured":"Swerdlow, A. J. et al. Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study. J. Clin. Endocrinol. Metab. 102, 1661\u20131672 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"52332_CR19","first-page":"577","volume":"89","author":"A Szil\u00e1gyi","year":"2000","unstructured":"Szil\u00e1gyi, A., Keszthelyi, G., Nagy, G. & Madlena, M. Oral manifestations of Patients with Turner syndrome. Oral Radiol. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endo. 89, 577\u2013584 (2000).","journal-title":"Endo."},{"key":"52332_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.18544\/PEDM-21.03.0036","volume":"21","author":"M Borkowska","year":"2015","unstructured":"Borkowska, M., Gawlik, A., Hankus, M. & Ma\u0142ecka-Tendera, E. Dental abnormalities and orthodontic disorders in Turner\u2019s syndrome patients. Pediatr. Endocrinol. Diabetes Metab. 21, 143\u2013148 (2015).","journal-title":"Endocrinol. Diabetes Metab."},{"key":"52332_CR21","doi-asserted-by":"crossref","unstructured":"Soares, M.Q. & Mendonca, E.F. Lichen planus-like drug reaction associated with recombinant human growth hormone therapy in a child patient with Turner syndrome. Dermatology Online Journal 22 pii: 13030\/qt4k61f5jn. (2016).","DOI":"10.5070\/D3223030374"},{"key":"52332_CR22","first-page":"837","volume":"22","author":"C Meazza","year":"2009","unstructured":"Meazza, C. et al. Effect of human recombinant growth hormone therapy on circulating levels of erythropoietin and granulocyte-colony stimulating factor in short children. J. Pediatr. Endocr. Met. 22, 837\u2013843 (2009).","journal-title":"J. Pediatr. Endocr. Met."},{"key":"52332_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12020-015-0591-0","volume":"50","author":"MP Kawa","year":"2015","unstructured":"Kawa, M. P. et al. Effects of growth hormone therapeutic supplementation on Hematopoietic stem\/progenitor cells in children with growth hormone deficiency: focus on proliferation and differentiation capabilities. Endocrine 50, 162\u2013175 (2015).","journal-title":"Endocrine"},{"key":"52332_CR24","doi-asserted-by":"publisher","unstructured":"Kawa, M.P. et al. The Impact of Growth Hormone Therapy on the Apoptosis Assessment in CD34+ Hematopoietic Cells from Children with Growth Hormone Deficiency. Int J Mol Sci 18 pii: E111. https:\/\/doi.org\/10.3390\/ijms18010111 (2017).","DOI":"10.3390\/ijms18010111"},{"key":"52332_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/BF00869745","volume":"6","author":"GD Ogle","year":"1992","unstructured":"Ogle, G. D., Rosenberg, A. R. & Kainer, G. Renal effects of growth hormone. I. Renal function and kidney growth. Pediatr. Nephrol. 6, 394\u2013398 (1992).","journal-title":"Pediatr. Nephrol."},{"key":"52332_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/j.ajkd.2014.05.024","volume":"65","author":"LA Bach","year":"2015","unstructured":"Bach, L. A. & Hale, L. J. Insulin-like growth factors and kidney disease. Am. J. Kidney Dis. 65, 327\u2013336 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"52332_CR27","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/ki.1993.376","volume":"44","author":"O Mehls","year":"1993","unstructured":"Mehls, O. et al. Effects of rhGH and rhIGF-1 on renal growth and morphology. Kidney Int. 44, 1251\u20131258 (1993).","journal-title":"Kidney Int."},{"key":"52332_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fmed.2017.00102","volume":"4","author":"D Mukhi","year":"2017","unstructured":"Mukhi, D., Nishad, R., Menon, R. K. & Pasupulati, A. K. Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy. Front. Med. (Lausanne) 4, 102, https:\/\/doi.org\/10.3389\/fmed.2017.00102 (2017).","journal-title":"Front. Med. (Lausanne)"},{"key":"52332_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s004670000315","volume":"14","author":"I Bilge","year":"2000","unstructured":"Bilge, I. et al. Frequency of renal malformations in Turner syndrome: analysis of 82 Turkish children. Pediatr. Nephrol. 14, 1111\u20131114 (2000).","journal-title":"Pediatr. Nephrol."},{"key":"52332_CR30","first-page":"602","volume":"63","author":"T Irzyniec","year":"2006","unstructured":"Irzyniec, T. & Je\u017c, W. Selected problems of the nephrological and urological status of women with Turner Syndrome. Przegl. Lek. 63, 602\u2013605 (2006).","journal-title":"Przegl. Lek."},{"key":"52332_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ghir.2011.01.003","volume":"21","author":"L Groban","year":"2011","unstructured":"Groban, L., Lin, M., Kassik, K. A., Ingram, L. R. & Sonntag, W. E. Early-onset Growth Hormone Deficiency Results in Diastolic Dysfunction in Adult-life and is Prevented by Growth Hormone Supplementation. Growth Horm. IGF Res. 21, 81\u201388 (2011).","journal-title":"Growth Horm. IGF Res."},{"key":"52332_CR32","first-page":"659","volume":"80","author":"R Valcavi","year":"1995","unstructured":"Valcavi, R. et al. Cardiac performance and mass in adult with hypopituitarism: effects of one year of growth treatment. J. Clin. Endocrinol. Metab. 80, 659\u2013666 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"52332_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1046\/j.1365-2265.1996.00820.x","volume":"45","author":"G Johannsson","year":"1996","unstructured":"Johannsson, G., Bengtsson, B. A., Andersson, B., Isgaard, J. & Caidahl, K. Long-term cardiovascular effects of growth hormone treatment in GH\u2212 deficient adults: preliminary data in a small group of patients. Clin. Endocrinol. 45, 305\u2013314 (1996).","journal-title":"Clin. Endocrinol."},{"key":"52332_CR34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1440-1673.1992.tb03152.x","volume":"36","author":"KL Dawson-Falk","year":"1992","unstructured":"Dawson-Falk, K. L. et al. Cardiovascular evaluation in Turner syndrome: utility of MR imaging. Australas. Radiol. 36, 204\u2013209 (1992).","journal-title":"Australas. Radiol."},{"key":"52332_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00246-013-0766-5","volume":"35","author":"JW Cramer","year":"2014","unstructured":"Cramer, J. W., Bartz, P. J., Simpson, P. M. & Zangwill, S. D. The spectrum of congenital heart disease and outcomes after surgical repair among children with Turner syndrome: a single-center review. Pediatr. Cardiol. 35, 253\u2013260 (2014).","journal-title":"Pediatr. Cardiol."},{"key":"52332_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1080\/09513590903015510","volume":"25","author":"W Je\u017c","year":"2009","unstructured":"Je\u017c, W. & Irzyniec, T. J. Hormonal replacement therapy in women with Turner\u2019s syndrome in Poland: Analysis of 176 cases. Gynecol. Endocrinol. 25, 546\u2013550 (2009).","journal-title":"Gynecol. Endocrinol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52332-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52332-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52332-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:20:24Z","timestamp":1671290424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52332-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52332"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52332-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"3 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15951"}}